ABSTRACT
Bacterial infection is the main cause of infectious diseases in children. Antibacterials play an important role in anti infection treatment of children. At present, the treatment of antimicrobial drugs in children is facing a severe situation of bacterial resistance. In January 2020, a children′s specialized hospital carried out the practice of precise management of antibiotics in combination with key performance indicators. Through the multi sectoral linkage of management and technology, eight key performance indicators and assessment methods were set up from three levels of antibiotic use, bacterial resistance and hospital infection, to standardize the clinical application of antibiotics and continue to promote the rational use of antibiotics. This practice had improved the performance indicators of antibacterial management. Among them, the use intensity of antibacterial drugs for inpatients decreased from 40.07 DDD in 2019 to 29.00 DDD in 2021, the use rate of antibacterial drugs for inpatients decreased from 81.32% to 64.40%, the percentage of antibacterial drug expenses in total drug expenses decreased from 35.41% to 26.82%, the use proportion of non restricted antibacterial drugs in antibacterial drugs increased from 71.30% to 82.21%, and the drug resistance rate of Salmonella to β-Lactam/enzyme inhibitors decreased from 4.84% to 0.03%, and the incidence of hospital infection decreased from 1.16% to 0.96%. The precise management of antibiotics in combination with key performance indicators improved the level of rational use of antibiotics, effectively curbed bacterial resistance, achieved phased results, so as to provide a reference for the scientific management of antibiotics in children′s hospitals.
ABSTRACT
A 13-year-old male patient presented with skin abnormalities for more than 10 years and slow growth in body height for more than 5 years. Since the age of 6 months, erythema and scales had occurred on the extremities, and gradually spread to the trunk and face; brown pigmentation and punctate depigmentation appeared after subsidance of the erythema and scales, accompanied by dental caries, thickened palms and soles, nail thickening and peeling. Since the age of 6 years, the patient had presented with slow growth in body height, gonadal dysgenesis, sparse eyebrows and eyelashes, flat cheekbones and lameness in walking. In the past 10 years, neutrophil count had been found to be continuously lower than the normal reference value. Blood routine examination showed a neutrophil count of 1.1 × 10 9/L and a neutrophil proportion of 0.345; serum level of testosterone in the patient (< 0.087 nmol/L) was lower than normal levels. DNA was extracted from the peripheral blood of the patient and his parents, and gene mutation analysis was carried out by using whole-exome sequencing technology. Genetic testing showed compound heterozygous mutations in the USB1 gene of the patient, including the c.450-2A>G mutation inherited from his mother and the c.335de1G mutation inherited from his father, and the c.335de1G mutation had not been reported in China and other countries.
ABSTRACT
Objective To study the effects of dust mite immunotherapy on the hormonal dosage, specific immunoglobulins G4(sIgG4)level and pulmonary function in asthmatic children.Methods One hundred and twenty-four cases of asthmatic children were randomly divided into specific immunotherapy treatment(SIT) group (62 cases, treated with the dust mite immunotherapy) and inhaled corticosteroids (ICS) group (62 cases, treated with ICS). The changes of clinical symptoms, serum sIgG4 level, pulmonary function and ICS dosage before and after treatment were compared between two groups. Results After treatment for 12,18,and 24 months, the scores of childhood asthma control test(C-ACT) in SIT group were significantly higher than those in ICS group:(23.84 ± 1.15)scores vs.(22.75 ± 1.08) scores, (24.29 ± 1.27)scores vs.(23.17 ± 1.22)scores, (24.83 ± 1.40)scores vs.(23.88 ± 1.34)scores, there were significant differences (P<0.05). After treatment for 12, 24 months, the level of serum sIgG4 in SIT group were significantly higher than those in ICS group:(308.75 ± 102.96) μg/L vs. (239.64 ± 79.35) μg/L, (542.28 ± 113.37) μg/L vs. (243.65 ± 80.21) μg/L, there were significant differences (P<0.05). After treatment for 12, 24 months, the levels of percentage of forced expiratory volume in 1 second (FEV1%), percentage of maximal expiratory flow rate (PEF%) in SIT group were significantly higher than those in ICS group: FEV1%:(95.82 ± 7.64)% vs. (92.79 ± 8.52)%, (99.52 ± 8.17)% vs.(95.89 ± 7.53)%;PEF%:(95.78 ± 5.85)% vs.(93.54 ± 6.18)%,(99.77 ± 5.69)% vs. (97.61 ± 5.56)%, there were significant differences (P<0.05). After treatment for 12, 24 months, the scores of daytime asthma symptoms scale (DAS) and nocturnal asthma symptoms scale (NAS) in SIT group were significantly lower than those in ICS group:DAS:(1.75 ± 0.54)scores vs.(1.96 ± 0.60)scores, (0.84 ± 0.27) scores vs. (1.19 ± 0.38) scores;NAS: (0.75 ± 0.27) scores vs.(0.92 ± 0.30) scores, (0.55 ± 0.18)scores vs.(0.81 ± 0.24)scores, there were significant differences(P<0.05).After treatment for 12, 24 months, the dosage in SIT group was significantly lower than those in ICS group:(172.08±16.73)μg/d vs.(194.63 ± 14.17)μg/d,(138.09 ± 16.23)μg/d vs.(163.15 ± 15.38)μg/d, there were significant differences(P<0.05).Conclusions Dust mite immunotherapy can effectively improve the clinical symptoms and pulmonary function in children with dust mite allergy asthma and reduce the ICS dosage, it may be related to the increase of protective antibody sIgG4 in children.
ABSTRACT
Objective To investigate the changes of airway function in different stages of asthma and its detection value.Methods One hundred and twenty children with acute exacerbation of asthma were selected as acute exacerbation group. The children were treated with routine asthma for 1 month. After that, children went into chronic duration (chronic duration group). The pulmonary function was measured in acute exacerbation group and chronic duration group,and the indexes were compared with those of 60 healthy children(healthy control group). Results The pulmonary function indexes of large airway forced vital capacity(FVC),peak expiratory flow(PEF),forced expired volume in 1 second(FEV1) and FEV1/FVC in acute exacerbation group were significantly lower than those in healthy control group and chronic duration group:(1.398 ± 0.518)L vs.(1.942 ± 0.557)and(1.851 ± 0.453)L,(2.701 ± 0.901) L/s vs.(4.102 ± 0.971)and(3.840 ± 1.001)L/s,(1.201 ± 0.316)L vs.(1.841 ± 0.499)and(1.690 ± 0.401) L, (86.337 ± 8.769)% vs. (96.589 ± 4.069)% and (94.317 ± 6.311)%, and there were statistical differences (P<0.05). The FEV1/FVC in chronic duration group was significantly lower than that in healthy control group,and there was statistical difference(P<0.05).There were no statistical differences in FVC, PEF and FEV1between chronic duration group and healthy control group (P>0.05). The pulmonary function indexes of small air channel forced expired flow at 25% of FVE (FEF25%), forced expired flow at 50% FVE (FEF50%), forced expired flow at 75% of FVE (FEF75%) and maximal midexpiratory flow (MMEF) in acute exacerbation group were significantly lower than those in healthy control group and chronic duration group:(2.187 ± 0.866)L/s vs.(3.869 ± 0.891)and(3.489 ± 0.947)L/s, (1.291 ± 0.549)L/s vs.(2.871 ± 0.584)and(2.599 ± 0.701)L/s,(0.596 ± 0.231)L/s vs.(1.412 ± 0.461) and(1.191 ± 0.571)L/s,(1.087 ± 0.496)L/s vs.(2.507 ± 0.629)and(2.259 ± 0.584)L/s,the indexes in chronic duration group were significantly lower than those in healthy control group, and there were statistical differences (P<0.05). Conclusions The lung function is abnormal in asthma children with acute exacerbation.After entering the chronic duration,the lung function appears to be improved,and the large airway function indexes return to normal. The small airway function indexes do not recover completely.Therefore,the detection of small airway function has great value in the diagnosis,severity and treatment of asthmatic children.